The Serum Institute of India is preparing to produce 1.1 billion doses of Novavax's COVID-19 vaccine in the country, NITI Aayog member Vinod Kumar Paul said at a press briefing on Tuesday.

Novavax vaccine efficacy data promising, clinical trials in India in advanced stage, says VK Paul

Novavax Inc on Monday reported late-stage data from its US-based clinical trial showing its vaccine is more than 90 per cent effective against COVID-19 across a variety of variants of the virus.

US biotech firm Novavax says COVID-19 jab is over 90% effective

novavax-efficacy

Novavax Efficacy, News on Novavax Efficacy, stories on Novavax Efficacy, articles on Novavax Efficacy, Novavax Efficacy stories at Wion, Novavax Efficacy news, Novavax Efficacy latest news

novavax efficacy

Novavax vaccine efficacy data promising, clinical trials in India in advanced stage, says VK Paul

US biotech firm Novavax says COVID-19 jab is over 90% effective